The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Efficacy and Safety of the Neuraminidase Inhibitor Zanamivirin the Treatment of Influenza A and B Virus Infections
Abstract
The efficacy and safety of zanamivir, administered 2x or 4x daily over 5 days, was evaluated in the treatment of influenza infections. A total of 1256 patients entered the study; 57% of those randomized had laboratory-confirmed influenza infection. The primary end point, "alleviation of major symptoms," was created to evaluate differences in clinical impact. In the overall population with or without influenza infection, zanamivir reduced the median number of days to reach this end point by 1 day (P=.012 2x daily vs. placebo; P=.014 4x daily vs. placebo). The reduction was greater in patients treated within 30 h of symptom onset, febrile at study entry, and in defined high-risk groups. Zanamivir reduced nights of disturbed sleep, time to resumption of normal activities, and use of symptom relief medications. It was well tolerated. These results suggest that zanamivir can significantly reduce the duration and overall symptomatic effect of influenza.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1994) · doi:10.1201/9780429246593 · Cited by 40,500
Statistical Methods for Rates and Proportions
Fleiss, J. L., Levin, B., & Paik, M. C. (2003) · Wiley Series in Probability and Statistics · doi:10.1002/0471445428 · Cited by 18,646
Statistical Methods for Rates and Proportions, 2nd ed
GROVE, W. A. (1981) · American Journal of Psychiatry · doi:10.1176/ajp.138.12.1644-a · Cited by 3,748
Nonparametrics: Statistical Methods Based on Ranks
Mergenthaler, M. J., & Lehmann, E. L. (1979) · Technometrics · doi:10.2307/1268531 · Cited by 3,329
More powerful procedures for multiple significance testing
Hochberg, Y., & Benjamini, Y. (1990) · Statistics in Medicine · doi:10.1002/sim.4780090710 · Cited by 2,715
Rational design of potent sialidase-based inhibitors of influenza virus replication
von Itzstein, M., Wu, W.-Y., Kok, G. B., Pegg, M. S., Dyason, J. C., Jin, B., Van Phan, T., Smythe, M. L., White, H. F., Oliver, S. W., et al. (1993) · Nature · doi:10.1038/363418a0 · Cited by 1,862
Hayden, F. G., Osterhaus, A. D. M. E., Treanor, J. J., Fleming, D. M., Aoki, F. Y., Nicholson, K. G., Bohnen, A. M., Hirst, H. M., Keene, O., & Wightman, K. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709253371302 · Cited by 762
Self-citationOptions for the control of influenza III
Ada, G. L., Tannock, G. A., & Hampson, A. W. (1997) · Vaccine · doi:10.1016/s0264-410x(96)00191-0 · Cited by 587
Evidence for Zanamivir Resistance in an Immunocompromised Child Infected with Influenza B Virus
Gubareva, L. V., Matrosovich, M. N., Brenner, M. K., Bethell, R. C., & Webster, R. G. (1998) · The Journal of Infectious Diseases · doi:10.1086/314440 · Cited by 432
Emergence and Apparent Transmission of Rimantadine-Resistant Influenza A Virus in Families
Hayden, F. G., Belshe, R. B., Clover, R. D., Hay, A. J., Oakes, M. G., & Soo, W. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912213212502 · Cited by 416
Woods, J. M., Bethell, R. C., Coates, J. A., Healy, N., Hiscox, S. A., Pearson, B. A., Ryan, D. M., Ticehurst, J., Tilling, J., & Walcott, S. M. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.7.1473 · Cited by 312
The neuraminidase of influenza virus
Air, G. M., & Laver, W. G. (1989) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340060402 · Cited by 303
Safety and Efficacy of the Neuraminidase Inhibitor GG167 in Experimental Human Influenza
Hayden, F. G. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530280047035 · Cited by 291
TECUMSEH STUDY OF ILLNESS. XIII. INFLUENZA INFECTION AND DISEASE, 1976–1981
MONTO, A. S., KOOPMAN, J. S., & LONGINI, I. M. (1985) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114052 · Cited by 291
Self-citationIntranasal drug delivery by spray and drops
Hardy, J. G., Lee, S. W., & Wilson, C. G. (1985) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1985.tb05069.x · Cited by 250
Wingfield, W. L., Pollack, D., & Grunert, R. R. (1969) · New England Journal of Medicine · doi:10.1056/nejm196909112811102 · Cited by 234
Successful Treatment of Naturally Occurring Influenza A/USSR/77 H1N1
Van Voris, L. P. (1981) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1981.03310360020016 · Cited by 212
Prophylaxis and Treatment of Influenza
Oates, J. A., Wood, A. J. J., & Douglas, R. G. (1990) · New England Journal of Medicine · doi:10.1056/nejm199002153220706 · Cited by 209
Estimates of the US health impact of influenza.
Sullivan, K. M., Monto, A. S., & Longini, I. M. (1993) · American Journal of Public Health · doi:10.2105/ajph.83.12.1712 · Cited by 166
Self-citationHolzer, C. T., von Itzstein, M., Jin, B., Pegg, M. S., Stewart, W. P., & Wu, W.-Y. (1993) · Glycoconjugate Journal · doi:10.1007/bf00731185 · Cited by 155
Mast, E. E., Harmon, M. W., Gravenstein, S., Wu, S. P., Arden, N. H., Circo, R., Tyszka, G., Kendal, A. P., & Davis, J. P. (1991) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116184 · Cited by 153
Ryan, D., Ticehurst, J. R., Dempsey, M. H., & Penn, C. R. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.10.2270 · Cited by 144
Liu, C., & Air, G. M. (1993) · Virology · doi:10.1006/viro.1993.1276 · Cited by 117
von Itzstein, M., Dyason, J. C., Oliver, S. W., White, H. F., Wu, W.-Y., Kok, G. B., & Pegg, M. S. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950294c · Cited by 115
A New Approach to the Analysis of Clinical Drug Trials with Withdrawals
Gould, A. L. (1980) · Biometrics · doi:10.2307/2556126 · Cited by 113
Intranasal Interferon- 2, Treatment of Experimental Rhinoviral Colds
Hayden, F. G., & Gwaltney, J. M. (1984) · Journal of Infectious Diseases · doi:10.1093/infdis/150.2.174 · Cited by 109
Influenza: Quantifying morbidity and mortality
Monto, A. S. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90556-0 · Cited by 99
Self-citationVisual Hallucinations and Delirium During Treatment with Amantadine (Symmetrel)
Postma, J. U., & van Tilburg, W. (1975) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1975.tb00187.x · Cited by 96
Distribution and removal of human serum albumin‐technetium 99m instilled intranasally.
Aoki, F. Y., & Crowley, J. (1976) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1976.tb00640.x · Cited by 90
Oral rimantadine hydrochloride therapy of influenza A virus H3N2 subtype infection in adults
Hayden, F. G., & Monto, A. S. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.29.2.339 · Cited by 80
Self-citationImplications of Viral Resistance to Amantadine in Control of Influenza A
Monto, A. S., & Arden, N. H. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/15.2.362 · Cited by 77
Self-citationINFLUENZA B VIRUS INFECTIONS IN THE COMMUNITY AND THE FAMILY
FRANK, A. L., Taber, L. H., Glezen, W. P., GEYER, E. A., McILWAIN, S., & Paredes, A. (1983) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113638 · Cited by 70
MUCINS AND MUCOIDS IN RELATION TO INFLUENZA VIRUS ACTION
Burnet, F. M. (1948) · Immunology and Cell Biology · doi:10.1038/icb.1948.39 · Cited by 63
Monto, A. S., Ohmit, S. E., Hornbuckle, K., & Pearce, C. L. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.10.2224 · Cited by 55
Self-citationHayden, F. G., Rollins, B. S., & Madren, L. K. (1994) · Antiviral Research · doi:10.1016/0166-3542(94)90101-5 · Cited by 53
Sabin, A. B. (1967) · JAMA · doi:10.1001/jama.200.11.943 · Cited by 42
Koch, G. G., & Sollecito, W. A. (1984) · Drug Information Journal · doi:10.1177/009286158401800204 · Cited by 27
Cited by
Mandell, L. A., Wunderink, R. G., Anzueto, A., Bartlett, J. G., Campbell, G. D., Dean, N. C., Dowell, S. F., File, T. M., Musher, D. M., Niederman, M. S., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/511159 · Cited by 6,202
(2001) · PsycEXTRA Dataset · doi:10.1037/e548312006-001 · Cited by 5,011
Niederman, M. S., Mandell, L. A., Anzueto, A., Bass, J. B., Broughton, W. A., Campbell, G. D., Dean, N., File, T., Fine, M. J., Gross, P. A., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.7.at1010 · Cited by 2,150
Avian Influenza A (H5N1) Infection in Humans
(2005) · New England Journal of Medicine · doi:10.1056/nejmra052211 · Cited by 1,285
Metadata
- Authors
- Monto, A. S., Fleming, D. M., Henry, D., de Groot, R., Makela, M., Klein, T., Elliott, M., Keene, O. N., & Man, C. Y.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-08
- Volume
- 180
- Issue
- 2
- Pages
- 254-261
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2046339130
- Cited by
- 275
- References
- 37
- FWCI
- 23.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.